Back to results
US 2020/0345766 A1Published application
Pharmaceutical compositions
AssigneeVifor Fresenius Medical Care Renal Pharma Ltd
InventorsLudwig Daniel WEIBEL, Erik PHILIPP
Life of this patent
Estimating the term…
Abstract
Pharmaceutical compositions for oral administration, in particular administration as an oral delivery system to be swallowed directly or capable of disintegration in the oral cavity, comprising iron oxy-hydroxide in high loading.
Claims27
1-25. (canceled)
A pharmaceutical composition comprising iron oxy-hydroxide, saccharose, and starch,
- wherein the total amount of iron oxy-hydroxide, saccharose, and starch is greater than 70% (w/w) expressed relative to the total weight of the composition,
- wherein the iron oxy-hydroxide is stabilized by at least saccharose and/or starch,
- wherein the composition is in a form of a chewable tablet,
- wherein the iron oxy-hydroxide comprises beta iron oxy-hydroxide,
- wherein the iron oxy-hydroxide is essentially non-bioabsorbable, and
- wherein the amount of iron oxy-hydroxide per tablet is 700 mg to 1700 mg.
3 more elements
A pharmaceutical composition comprising iron oxy-hydroxide, saccharose, and starch,
- wherein the total amount of iron oxy-hydroxide, saccharose, and starch is greater than 70% (w/w) expressed relative to the total weight of the composition,
- wherein the iron oxy-hydroxide is stabilized by at least saccharose and/or starch,
- wherein the composition is in a form of a chewable tablet,
- wherein the iron oxy-hydroxide comprises beta iron oxy-hydroxide,
- wherein the iron oxy-hydroxide is essentially non-bioabsorbable, and
- wherein the amount of iron oxy-hydroxide per tablet is about 800 mg.
3 more elements
Dependencies are inferred from the claim text.